Search Results - "ROSILIO, M"

Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) project by Galan, B. E., McCrimmon, R. J., Ibberson, M., Heller, S. R., Choudhary, P., Pouwer, F., Speight, J., Carlton, J., Pieber, T. R., Rosilio, M., Tack, C. J., Müllenborn, M.

“…Background Hypoglycaemia is the most frequent complication of treatment with insulin or insulin secretagogues in people with diabetes. Severe hypoglycaemia,…”
Get full text

Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3 by Bergenstal, R. M., Lunt, H., Franek, E., Travert, F., Mou, J., Qu, Y., Antalis, C. J., Hartman, M. L., Rosilio, M., Jacober, S. J., Bastyr III, E. J.

“…Aims To compare the efficacy and safety of basal insulin peglispro (BIL), which has a flat pharmacokinetic and pharmacodynamic profile and a long duration of…”
Get full text

High incidence of SHOX anomalies in individuals with short stature by Huber, C, Rosilio, M, Munnich, A, Cormier-Daire, V

“…Objective: To study the SHOX gene and the PAR1 region in individuals with short stature. Methods: The study involved 56 cases of dyschondrosteosis and 84 cases…”
Get full text

Epidemiology of diabetic retinopathy: Expected vs reported prevalence of cases in the French population by Delcourt, C, Massin, P, Rosilio, M

“…Abstract Aim and methods Impaired eyesight and vision loss due to retinopathy are among the most feared complications in diabetic patients. As the number of…”
Get full text

A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1 by Garg, S., Dreyer, M., Jinnouchi, H., Mou, J., Qu, Y., Hartman, M. L., Rosilio, M., Jacober, S. J., Bastyr III, E. J.

“…Aims The primary objective was to demonstrate that basal insulin peglispro (BIL) was non‐inferior compared with insulin glargine (GL) for haemoglobin A1c…”
Get full text

Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France by Wu, E. Q., Borton, J., Said, G., Le, T. K., Monz, B., Rosilio, M., Avoinet, S.

“…ABSTRACT Objective: To estimate the point prevalence of diabetic peripheral neuropathy (DPN) and pain associated with DPN (pDPN) in French adults with diabetes…”
Get full text

Factors associated with glycemic control: a cross-sectional nationwide study in 2,579 French children with type 1 diabetes by Rosilio, M. (INSERM, Paris.), Cotton, J.B, Wieliczko, M.C, Gendrault, B, Carel, J.C, Couvaras, O, Ser, N, Gillet, P, Soskin, S, Garandeau, P

“…OBJECTIVE To determine on a large scale the multiple medical and nonmedical factors that influence glycemic control in the general population of children with…”
Get full text

CA-014: Réduction supérieure de l'HbA1c avec l'insuline Peglispro (BIL) vs glargine (GL) dans une étude randomisée en double aveugle chez des patients diabètiques de type 1 (DT1) : IMAGINE 3 by Lunt, H, Bergenstal, R, Franek, E, Mou, J, Hartman, M, Rosilio, M, Bastyr, E.J, Travert, F

“…Introduction L'insuline peglispro (BIL) est une nouvelle insuline basale avec un profil pharmacocinétique plat, et une action hépato-préférentielle résultant…”
Get full text

Tailles finales des enfants avec déficit du gène SHOX traités par hormone de croissance (GH) : description des données issues d’études observationnelle et d’essai clinique by Benabbad, I, Child, C.J, Carel, J.C, Rosilio, M

“…L’essai multicentrique dans l’indication « déficit du gène SHOX  » a montré que le traitement par GH a permis une augmentation de la vitesse de croissance(VC)…”
Get full text

Low dose linomide in Type I juvenile diabetes of recent onset : a randomised placebo-controlled double blind trial by COUTANT, R, LANDAIS, P, ROSILIO, M, JOHNSEN, C, LAHLOU, N, CHATELAIN, P, CAREL, J. C, LUDVIGSSON, J, BOITARD, C, BOUGNERES, P. F

“…The quinoline-3-carboxamide, linomide, protects non-obese diabetic mice from diabetes. The effects of linomide on insulin needs and beta cell function were…”
Get full text

P79 - Conversation MapTM (MAP) : exemple de mise en place d’un outil d’éducation thérapeutique à large échelle by Mosnier-Pudar, H, Herdt, C, Durain, D, Vincent, S, Rosilio, M, Morel, V, Hochberg, G

“…Introduction Conversation MapTM (MAP) est un outil éducatif, créé en collaboration avec la région Europe de la Fédération Internationale du Diabète, mis à…”
Get full text

P223 Influence des triglycérides sur la fréquence cardiaque et sa variabilité. Données de la cohorte D.E.S.I.R by Valensi, P, Extramania, F, Lange, C, Maisonblanche, P, Haggui, A, Rosilio, M, Tichet, J, Cailleau, M, Balkau, B

“…Introduction Certaines études ont suggéré le rôle de l’obésité et de l’insulinorésistance dans les altérations de la variabilité de la fréquence cardiaque…”
Get full text

P40 Influence de l’excès de poids et de la dysglycémie sur la fréquence cardiaque et sa variabilité. Données de la cohorte D.E.S.I.R by Valensi, P, Extramiana, F, Lange, C, Maisonblanche, P, Haggui, A, Rosilio, M, Tichet, J, Cailleau, M, Balkau, B

“…Introduction Les variations de la fréquence cardiaque (VFC) sont réduites chez l’obèse. Le but était d’évaluer l’influence respective du statut glycémique et…”
Get full text

O67 L’HbA1c et la glycémie à jeun sont prédictifs de la rétinopathie à 10 ans by Massin, P, Lange, C, Tichet, J, Rosilio, M, Vol, S, Erginay, A, Cailleau, M, Eschwège, E, Balkau, B

“…Objectif Comparer les valeurs prédictives à 10 ans de l’HbA1c et de la glycémie à jeun pour la rétinopathie. Patients et méthodes Une rétinopathie a été…”
Get full text

Serotoninergic modulation of sodium appetite in the rat by Rouah-Rosilio, M, Orosco, M, Nicolaidis, S

“…There are two mechanisms leading to an enhancement of salt intake: one is induced by a sodium deficit and the other is need-free. The serotonin involvement in…”
Get more information

PDB3 The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide & Liraglutide in Type 2 Diabetes Patients (TROPHIES): 6-Month Analysis Results by Giorgino, F., Guerci, B., García-Pérez, L.E., Boye, K., Aigner, U., Heitmann, E., Orsini Federici, M., Zimner-Rapuch, S., Rosilio, M., Norrbacka, K., Sapin, H.

Get full text

PDB113 THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): PATIENT-REPORTED OUTCOMES AT BASELINE by Boye, K., García-Pérez, L.E., Sapin, H., Rosilio, M., Orsini Federici, M., Heitmann, E., Jung, H., Gentilella, R., Aigner, U., Guerci, B., Giorgino, F., Norrbacka, K.

Get full text

PDB116 THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): DESIGN AND BASELINE CHARACTERISTICS by García-Pérez, L.E., Sapin, H., Norrbacka, K., Guerci, B., Giorgino, F., Aigner, U., Orsini Federici, M., Gentilella, R., Heitmann, E., Jung, H., Rosilio, M., Boye, K.

Get full text

PDB82 THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE AND LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): COUNTRY-SPECIFIC BASELINE CHARACTERISTICS by Sapin, H., García-Pérez, L.E., Norrbacka, K., Giorgino, F., Guerci, B., Aigner, U., Orsini Federici, M., Gentilella, R., Heitmann, E., Jung, H., Rosilio, M., Boye, K.

Get full text

Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis by Rieu, M, Richard, A, Rosilio, M, Laplanche, S, Ropion, V, Fombeur, J P, Berrod, J L

“…In patients with hypothyroid goitrous Hashimoto's thyroiditis, the recovery from hypothyroidism seems to be due to a spontaneous decrease of antibodies (Ab) to…”
Get more information